Dalnicastobart Biosimilar - Research Grade

Human

CD40ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P25942

Blue ice

CD40 is a costimulatory receptor on antigen-presenting cells that orchestrates B-cell, dendritic-cell and macrophage activation, a central pathway in immunology research. Offered as an unconjugated, non-therapeutic analog of dalnicastobart, this human IgG1-kappa recombinant antibody is intended for research use only. It is provided in a low-endotoxin, in vivo-suitable format and manufactured in scalable milligram-to-gram quantities for high-throughput laboratories. The antibody supports functional assays, costimulation and immune-activation studies, ADCC analysis, in vitro screening and preclinical immune-modulation models examining CD40 signaling. Supplied low in endotoxin and built to in vivo standards, it scales from milligram to gram quantities for bulk, reagent-intensive workflows.

CD40, Bp50, CDW40, TNFRSF5, p50, CD40 (protein), CD40 molecule

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks